cell and gene therapies - International Biopharmaceutical Industry

Current Edition

Volume 5 Issue 3

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

There is growing excitement about the potential shown by cell and gene therapies, particularly in rare diseases. First, though, these therapies face challenges both i...

12 October 2022 Volume 5 Issue 3 achieving | advanced

Continue Reading →

Volume 4 Issue 3

Regulatory Challenges Associated with the Development of Cell and Gene Therapies

The development of safe and effective cell and gene therapies (CGTs) relies on regulatory compliance and critical selection and qualification of raw materials. Regula...

1 September 2021 Volume 4 Issue 3 cell and gene therapies | cell therapies

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

Regulatory Challenges Associated with the Development of Cell and Gene Therapies

International Biopharmaceutical Industry